We are live on
!
Find out more
SCP
Shorepoint Capital Partners Portfolio holdings
AUM
$503M
This Fund
S&P 500
This Quarter
Est. Return
+2.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
-$1.38M
(-0.78%)
Cap. Flow
-$5.75M
Cap. Flow
% of AUM
-3.28%
Top 10 Holdings %
Top 10 Hldgs %
31.53%
Holding
90
New
4
Increased
17
Reduced
60
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHI
Calamos Convertible Opportunities and Income Fund
CHI
|
+$831K |
| 2 |
EFT
Eaton Vance Floating-Rate Income Trust
EFT
|
+$812K |
| 3 |
Occidental Petroleum
OXY
|
+$716K |
| 4 |
Alcon
ALC
|
+$707K |
| 5 |
Tapestry
TPR
|
+$545K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameriprise Financial
AMP
|
+$949K |
| 2 |
Apple
AAPL
|
+$777K |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$772K |
| 4 |
Kraft Heinz
KHC
|
+$634K |
| 5 |
VF Corp
VFC
|
+$503K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.41% |
| 2 | Financials | 11.09% |
| 3 | Technology | 10.86% |
| 4 | Industrials | 8.15% |
| 5 | Consumer Discretionary | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Equinix
EQIX
$98.9B
| $455K | 0.26% |
903
-105
| -10% | -$50.4K |
|
77
Norfolk Southern
NSC
$75.7B
| $424K | 0.24% |
2,125
-25
| -1% | -$4.96K |
|
78
Alphabet (Google) Class C
GOOG
$4.06T
| $395K | 0.23% |
7,300
-1,860
| -20% | -$107K |
|
79
WEC Energy
WEC
$36.6B
| $375K | 0.21% |
4,500
| – | – |
|
80
Mondelez International
MDLZ
$84.2B
| $363K | 0.21% |
6,743
-1,250
| -16% | -$64.9K |
|
81
Schwab International Equity ETF
SCHF
$64.8B
| $323K | 0.18% |
20,120
| – | – |
|
82
Kimberly-Clark
KMB
$37.4B
| $263K | 0.15% |
1,971
-279
| -12% | -$36K |
|
83
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$778M
| $249K | 0.14% |
12,300
+800
| +7% | +$15.6K |
|
84
Southern Company
SO
$109B
| $249K | 0.14% |
4,500
| – | – |
|
85
Consolidated Edison
ED
$41.5B
| $223K | 0.13% |
2,546
| – | – |
|
86
Northrop Grumman
NOC
$77.2B
| $218K | 0.12% |
+675
| New | +$201K |
|
|
87
Ameriprise Financial
AMP
$48.1B
| $215K | 0.12% |
1,480
-6,566
| -82% | -$949K |
|
|
88
Teva Pharmaceuticals
TEVA
$39.9B
| – | – |
-49,215
| Closed | -$772K |
|
89
TJX Companies
TJX
$180B
| – | – |
-4,371
| Closed | -$233K |
|
|
RAD
90
DELISTED
Rite Aid Corporation
RAD
| – | – |
-900
| Closed | -$11K |
|
Similar funds
VBFG
JWM
FNC
OHWA
ODG
GP
SCA
SFPM
Shorepoint Capital Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Shorepoint Capital Partners held 90 positions worth $175M, down 0.78% from $177M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Shorepoint Capital Partners withdrew a net $5.75M in Q2 2019, closing 3 positions and reducing 60 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $772K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Financials and Technology.
Against the trend, Shorepoint Capital Partners opened a new position in Calamos Convertible Opportunities and Income Fund worth $840K.
- Shorepoint Capital Partners's largest Q2 2019 buy was Calamos Convertible Opportunities and Income Fund: 80,000 shares worth $840K.
- Shorepoint Capital Partners added most to Occidental Petroleum in Q2 2019, an estimated $716K increase.
- Shorepoint Capital Partners's biggest Q2 2019 reduction was Ameriprise Financial, cutting an estimated $949K.
- Shorepoint Capital Partners fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $772K.
- Shorepoint Capital Partners's ten largest holdings make up 32% of its $175M portfolio in Q2 2019.
- Shorepoint Capital Partners opened 4 new positions and closed 3 in Q2 2019.
- Shorepoint Capital Partners's portfolio value fell 0.78% quarter-over-quarter to $175M.
Based on Shorepoint Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.